|
1
|
Valeyre D, Prasse A, Nunes H, Uzunhan Y,
Brillet PY and Müller-Quernheim J: Sarcoidosis. Lancet.
383:1155–1167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Salah S, Abad S, Monnet D and Brézin AP:
Sarcoidosis. J Fr Ophtalmol. 41:e451–e467. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Spagnolo P: Sarcoidosis: A critical review
of history and milestones. Clin Rev Allergy Immunol. 49:1–5.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gundlach BS, Maya MM and Tsui I: Worsening
floaters in a 68-year-old white woman. JAMA Ophthalmol.
139:353–354. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sharma S, Ghosh B and Sharma SK:
Association of TNF polymorphisms with sarcoidosis, its prognosis
and tumour necrosis factor (TNF)-alpha levels in Asian Indians.
Clin Exp Immunol. 151:251–259. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Morimoto T, Azuma A, Abe S, Usuki J, Kudoh
S, Sugisaki K, Oritsu M and Nukiwa T: Epidemiology of sarcoidosis
in Japan. Eur Respir J. 31:372–379. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Llanos O and Hamzeh N: Sarcoidosis. Med
Clin North Am. 103:527–534. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pacheco Y: Éthiopathogénie de la
sarcoïdose (Pathogenesis of sarcoidosis). Rev Med Interne.
32:73–79. 2011.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
9
|
Oh-oka H, Yamada T, Noto H, Umeyama T,
Kadekawa K, Ashitomi K, Nishijima S and Sugaya K: Effect of
carbazochrome sodium sulfonate on refractory chronic prostatitis.
Int J Urol. 21:1162–1166. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ramos-Casals M, Retamozo S, Sisó-Almirall
A, Pérez-Alvarez R, Pallarés L and Brito-Zerón P: Clinically-useful
serum biomarkers for diagnosis and prognosis of sarcoidosis. Expert
Rev Clin Immunol. 15:391–405. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Grosso S, Margollicci MA, Bargagli E,
Buccoliero QR, Perrone A, Galimberti D, Morgese G, Balestri P and
Rottoli P: Serum levels of chitotriosidase as a marker of disease
activity and clinical stage in sarcoidosis. Scand J Clin Lab
Invest. 64:57–62. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cozier YC, Berman JS, Palmer JR, Boggs DA,
Serlin DM and Rosenberg L: Sarcoidosis in black women in the United
States. Chest. 139:144–150. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Baughman RP, Shlobin OA, Gupta R, Engel
PJ, Stewart JI, Lower EE, Rahaghi FF, Zeigler J and Nathan SD:
Riociguat for sarcoidosis-associated pulmonary hypertension:
Results of a 1-year double-blind, placebo-controlled trial. Chest.
161:448–457. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Markatis E, Afthinos A, Antonakis E and
Papanikolaou IC: Cardiac sarcoidosis: Diagnosis and management. Rev
Cardiovasc Med. 21(321)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gerke AK: Treatment of sarcoidosis: A
multidisciplinary approach. Front Immunol.
11(545413)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Buchman AL: Side effects of corticosteroid
therapy. J Clin Gastroenterol. 33:289–294. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Saggese G, Bertelloni S, Baroncelli GI and
Di Nero G: Ketoconazole decreases the serum ionized calcium and
1,25-dihydroxyvitamin D levels in tuberculosis-associated
hypercalcemia. Am J Dis Child. 147:270–273. 1993.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Mateo RCI, Ortiz R and Rosen HN:
Bisphosphonates for the treatment of calcitriol-induced
hypercalcemia. AACE Clin Case Rep. 5:e316–e320. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sinha AD and Agarwal R: Thiazide diuretics
in chronic kidney disease. Curr Hypertens Rep.
17(13)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Awasty SS, Jafri S, Manzoor S and Yaqub A:
Hypercalcemia secondary to immune reconstitution inflammatory
syndrome in an HIV-infected individual with mycobacterium avium
complex. Cureus. 21(e18174)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Adams JS, Singer FR, Gacad MA, Sharma OP,
Hayes MJ, Vouros P and Holick MF: Isolation and structural
identification of 1,25-dihydroxyvitamin D3 produced by cultured
alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab.
60:960–966. 1985.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rajkumar T, Lea-Henry T and Chacko B:
Acute kidney injury as the presenting manifestation of sarcoidosis:
A case series and review of literature. Nephrology (Carlton).
23:597–600. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Iannuzzi MC, Rybicki BA and Teirstein AS:
Sarcoidosis. N Engl J Med. 357:2153–2165. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Stehlé T, Boffa JJ, Lang P, Desvaux D,
Sahali D and Audard V: Atteintes rénales de la sarcoïdose (Kidney
involvement in sarcoidosis). Rev Med Interne. 34:538–544.
.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
25
|
Howard BA and Wong TZ: 18F-FDG-PET/CT
imaging for gastrointestinal malignancies. Radiol Clin North Am.
59:737–753. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Braun JJ, Kessler R, Constantinesco A and
Imperiale A: 18F-FDG PET/CT in sarcoidosis management: Review and
report of 20 cases. Eur J Nucl Med Mol Imaging. 35:1537–1543.
2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Horino T, Matsumoto T, Inoue K, Ichii O
and Terada Y: A case of acute kidney injury caused by granulomatous
interstitial nephritis associated with sarcoidosis. CEN Case Rep.
7:34–38. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Reichel H, Koeffler HP, Barbers R and
Norman AW: Regulation of 1,25-dihydroxyvitamin D3 production by
cultured alveolar macrophages from normal human donors and from
patients with pulmonary sarcoidosis. J Clin Endocrinol Metab.
65:1201–1209. 1987.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zerwekh JE, Pak CY, Kaplan RA, McGuire JL,
Upchurch K, Breslau N and Johnson R Jr: Pathogenetic role of 1
alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive
hypercalciuria: Different response to prednisolone therapy. J Clin
Endocrinol Metab. 51:381–386. 1980.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Joss N, Morris S, Young B and Geddes C:
Granulomatous interstitial nephritis. Clin J Am Soc Nephrol.
2:222–230. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Löffler C, Löffler U, Tuleweit A, Waldherr
R, Uppenkamp M and Bergner R: Renal sarcoidosis: Epidemiological
and follow-up data in a cohort of 27 patients. Sarcoidosis Vasc
Diffuse Lung Dis. 31:306–315. 2014.PubMed/NCBI
|
|
32
|
Londner C, Zendah I, Freynet O, Carton Z,
Dion G, Nunes H and Valeyre D: Traitement de la sarcoïdose
(Treatment of sarcoidosis). Rev Med Interne. 32:109–113.
2011.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
33
|
Mahévas M, Lescure FX, Boffa JJ, Delastour
V, Belenfant X, Chapelon C, Cordonnier C, Makdassi R, Piette JC,
Naccache JM, et al: Renal sarcoidosis: Clinical, laboratory, and
histologic presentation and outcome in 47 patients. Medicine
(Baltimore). 88:98–106. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zaidi AA, DeVita MV, Michelis MF and
Rosenstock JL: Mycophenolate mofetil as a steroid-sparing agent in
sarcoid-associated renal disease. Clin Nephrol. 83:41–44.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Judson MA, Baughman RP, Costabel U, Flavin
S, Lo KH, Kavuru MS, Drent M and Centocor T: 48 Sarcoidosis
Investigators. Efficacy of infliximab in extrapulmonary
sarcoidosis: Results from a randomised trial. Eur Respir J.
31:1189–1196. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Baughman RP and Lower EE: Treatment of
sarcoidosis. Clin Rev Allergy Immunol. 49:79–92. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Miyazaki E, Tsuda T, Mochizuki A, Sugisaki
K, Ando M, Matsumoto T, Sawabe T and Kumamoto T: Sarcoidosis
presenting as bilateral hydronephrosis. Intern Med. 35:579–582.
1996.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Leibovitch I, Selva D, Goldberg RA,
Sullivan TJ, Saeed P, Davis G, McCann JD, McNab A and Rootman J:
Periocular and orbital amyloidosis: Clinical characteristics,
management, and outcome. Ophthalmology. 113:1657–1664.
2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
El-Husseini A, Sabucedo AJ, Lamarche J,
Courville C and Peguero A: Atypical sarcoidosis diagnosed by bone
marrow biopsy during renal workup for possible multiple myeloma.
CEN Case Rep. 2:102–106. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rafat C, Bobrie G, Chedid A, Nochy D,
Hernigou A and Plouin PF: Sarcoidosis presenting as severe
renin-dependent hypertension due to kidney vascular injury. Clin
Kidney. 7:383–386. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Agrawal V, Crisi GM, D'Agati VD and Freda
BJ: Renal Sarcoidosis Presenting as Acute Kidney Injury With
Granulomatous Interstitial Nephritis and Vasculitis. Am J Kidney
Dis. 59:303–308. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bachmeyer C, Belaube N, Loi V, Wendum D,
Gauthé M and Haymann JP: Hypercalcemia and acute renal failure
indicating peritoneal sarcoidosis. Am J Med. 134:e571–e572.
2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ponce C and Gujral JS: Renal failure and
hypercalcemia as initial manifestations of extrapulmonary
sarcoidosis. Southern Med J. 97:590–592. 2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Karnchanasorn R, Sarikonda M, Aldasouqi S
and Gossain VV: Severe hypercalcemia and acute renal failure: An
unusual presentation of sarcoidosis. Case Rep Med.
2010(423659)2010.PubMed/NCBI View Article : Google Scholar
|
